HEMATOGEN
Hematogen Softgel capsule
Approved
Approval ID
c36cb9d3-f0a3-4d34-92f2-8ab281b26b7d
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 28, 2023
Manufacturers
FDA
Nnodum Pharmaceuticals
DUNS: 960457273
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
FERROUS FUMARATE, ASCORBIC ACID, INTRINSIC FACTOR , CYANOCOBALAMIN
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63044-631
Product Classification
G
Generic Name
FERROUS FUMARATE, ASCORBIC ACID, INTRINSIC FACTOR , CYANOCOBALAMIN
Product Specifications
Route of AdministrationORAL
Effective DateDecember 23, 2021
FDA Product Classification
INGREDIENTS (4)
FERROUS FUMARATEActive
Quantity: 66 mg in 1 1
Code: R5L488RY0Q
Classification: ACTIM
INTRINSIC FACTORActive
Quantity: 100 mg in 1 1
Code: 70BT6OQT2Q
Classification: ACTIB
CYANOCOBALAMINActive
Quantity: 10 ug in 1 1
Code: P6YC3EG204
Classification: ACTIB
ASCORBIC ACIDActive
Quantity: 250 mg in 1 1
Code: PQ6CK8PD0R
Classification: ACTIB